Immupharma Share Discussion Threads

[nobbygnome] 06/2/2020 08:49

With all due respect you should be concerned about who is going to do the trial. The chances are there will be delays because they don't have previous experience of running such a trial in SLE or indeed consulting with the FDA. The latter is very tricky at the best of times.

[marie1980] 06/2/2020 08:41

Again love you are going too much in a technical level.

Don’t.

As I said I don’t care. I’m here for 2-3 year view and even if I get 50% rise I would be super happy and I’m confident I will get that.

I don’t care in which you worked or what. Think logically, have long term view and invest.

Enjoy

[nobbygnome] 06/2/2020 08:35

I don't disagree that we won't know the result for years so nothing to worry about in the short term. However, Avion's inexperience in conducting such trials is a concern and shows that IMM really struggled to get anyone interested in licensing the drug.

The ultimate irony is that the anti DNA abs signal did not work on the US patients. You couldn't make it up....

[marie1980] 06/2/2020 08:30

Nobby,

I don’t know whether P3 works or not and I genuinely don’t care.

I invest here with a view of 2-3 years. And then get out right before P3 approval with FDA.

I don’t know and I don’t care about dosage or any technical things.

What I know is in 2 years of time, IMM share price will not be at 20ish. As simple as that.

[nobbygnome] 06/2/2020 08:26

Funny you should say that Marie. I would have designed a better phase III than IMM did! In case you don't realise I did work in precisely this field in Pharma for 28 years. My assessment of Lupuzor is based on an extensive review of the scientific literature published about the drug. All the clues are there to tell you it wouldn't work and how to solve the problems.

[marie1980] 06/2/2020 08:22

I think it shows Avion's inexperience in doing this sort of study.


— nobbby. They should have include you in their team rather than spending £25M in IMM lup Phase 3 trials.
You’re so sensible and intelligent make me wonder what are you doing here love ?

[nobbygnome] 06/2/2020 08:11

I agree it's essentially a non announcement. I am surprised it has taken this long to get going in terms of agreeing a plan and getting a FDA meeting.I think it shows Avion's inexperience in doing this sort of study.

[the stigologist] 06/2/2020 08:00

That suggests potential for multiple international deals and/or competitive tension in any licence discussions

[the stigologist] 06/2/2020 07:58

Avion and ImmuPharma to meet with the FDA in Q1 2020 to discuss guidance on a new optimised international Phase III trial protocol

· Positive discussions with a number of potential commercial partners of Lupuzor™ outside of the US

[ny boy] 06/2/2020 07:51

25p target on this bull flag, maybe not attainable this week. Stay invested for spectacular returns over the longer term though. GLA

[coldspring] 06/2/2020 07:39

To summarise since November there has been a committee meeting and it was decided they wish to meet the FDA to start the trial ASAP. That is the only new news I can see, the rest is repeated.Underwhelming is my initial thought on it.

[daveboy1] 06/2/2020 07:37

My kind of schizophrenic ringer - 40p on the ask at Vox.
Morning Ken.

[coldspring] 05/2/2020 19:53

Look at the trades and this is anything but a bull flag. Its schizophrenic in the extreme.....

[the stigologist] 05/2/2020 19:34

Looking like a very nice bull flag.

Expecting some positive news here soon which will see breakout to upside.

[marie1980] 05/2/2020 16:35

Not a single sell out of 17 trades

[marie1980] 04/2/2020 19:42

You’re welcome cold spring.
I like your name btw.

[coldspring] 04/2/2020 19:11

Lol accusing nobby of ramping this, he has been ultra negative on the bod, prospects of lupozor at current dose and particularly chairman Tim since almost before time began. Thanks for the laugh though much needed

[lord loads of lolly] 04/2/2020 18:48

nobbygnome - yes I vaguely remember you saying that a thousand times already. More puzzling is your Incanthera holding, given your views about its (& IMM's) Chairman. Doesn't quite add up old bean.